Tesla's Lithium Supply - Update

Tesla's Lithium Supply - Update By Randy Carlson • 214 comments Intel: Plans For 10 Nanometer And Beyond By Mark Hibben • 49 comments Valeant Gives Up Gains By Chris Lau • 133 comments PRO Pick of the Day Argos Therapeutics: Significant Unrecognized Value By The Game Changer • 26 comments PRO ideas are forward-looking, under-the-radar opportunities from top authors. The Game Changer's first SA article lays out the case for why Argos Therapeutics has significant value even amidst the typical sector risks. Learn more about SA Pro Editors' Picks Alibaba: Do You Know What You Are Buying? By Alexander Wilson Impinj: Strong Sell On Misplaced Amazon Go And IoT Hype By Black Mamba Exxon Is Not Immune To Permian Fever By Nikolai Gouliaev Very Strong U.S. Minivan Sales: Fiat Chrysler Now As Large As Honda And Toyota Combined By Anton Wahlman Chemtrade Has Just Made An Accretive Acquisition In A 'Moat' Business By Safety In Value More Editors' Picks» Long Ideas Citigroup: I Can't Imagine by Christopher F. Davis Looking At Nvidia's Competition by NextGenAnalysis Enterprise Products Partners: A Good Time To Buy? by Orthodox Investor Why I Am Buying Himax Technologies Today by Giovanni DiMauro J.C. Penney Company: Looks Like Easy Money by John Behan More Long Ideas» Quick Picks & Lists Bank Of America: Take Your Money And Run by Jeffrey Himelson Bank Of America: What Investors Can Reasonably Expect In 2017 by Alpha Source General Electric: Bold Moves To Cut Costs And Increase Focus by Anthony Ruben Airbus Did What Boeing Couldn't by Dhierin Bechai My 2017 Stock Picks by Crispus Nyaga More Quick Picks & Lists» Cramer's Picks Harley-Davidson Is A Long-Term Buy - Cramer's Lightning Round (1/18/17) by SA Editor Mohit Manghnani Earnings Are Moving Stocks - Cramer's Mad Money (1/18/17) by SA Editor Mohit Manghnani More Cramer's Picks» Insider Ownership InsiderInsights.com Daily Round Up 1/17/17: WPX, MRTI, OPK by InsiderInsights More Insider Ownership» IPO Analysis e.l.f. Beauty's IPO Lock-Up Expiration Is Looming by Isaac Legault Jounce Therapeutics Updates $75 Million IPO Terms by Donovan Jones Braeburn Pharmaceuticals Proposes $150 Million IPO Terms by Donovan Jones The New New Relic? A Side-By-Side Look At AppDynamics And Its Closest Peer by Renaissance Capital IPO Research Vanguard Of The Unicorns: AppDynamics Aims To Continue Strong Returns From 2016 Tech IPOs by Renaissance Capital IPO Research More IPO Analysis» Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio. Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha. Unsubscribe from this email or manage all your Seeking Alpha email choices here. To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017